DI
EBS icon

Disciplined Investments’s Emergent Biosolutions EBS Stock Holding History

Disciplined Investments’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12
Closed -$124 – 1700
2023
Q1 		$124 Hold
12
– – ﹤0.01% 1550
2022
Q4 		$142 Hold
12
– – ﹤0.01% 1492
2022
Q3 		$0 Buy
12
+6
+100% +$167 ﹤0.01% 1326
2022
Q2 		$0 Sell
6
-2
-25% -$68 ﹤0.01% 1352
2022
Q1 		$0 Buy
+8
New +$353 ﹤0.01% 1409

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Disciplined Investments's EBS Position: Q2 2023 in Review

Disciplined Investments sold out of Emergent Biosolutions (EBS) in Q2 2023, closing a stake of 12 shares — an estimated $124 sold.

Disciplined Investments first reported a position in EBS in Q1 2022 and held it in 5 quarters. The position peaked at $142 in Q4 2022. 183 funds tracked by Wall St. Rank hold EBS as of Q2 2023.

  • Disciplined Investments reported no remaining Emergent Biosolutions position as of Q2 2023 after selling out during the quarter.
  • Disciplined Investments sold 12 Emergent Biosolutions shares in Q2 2023, an estimated $124.
  • Disciplined Investments first reported a position in Emergent Biosolutions in Q1 2022 and held it in 5 quarters.
  • Disciplined Investments's Emergent Biosolutions position peaked at $142 in Q4 2022.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2023.

Based on Disciplined Investments's 13F filing for Q2 2023, filed 10 Jul 2023.